BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, July 16, 2026
Home
»
Authors
» Douglas Merrill
Douglas Merrill
Articles
ARTICLES
TeGenero Case May Prompt Tighter Clinical Trial Control
March 22, 2006
By
Douglas Merrill
TeGenero Case May Prompt Tighter Clinical Trial Control
March 22, 2006
By
Douglas Merrill
Vasopharm Receives EUR9.7M To Advance Head Injury Product
Feb. 1, 2006
By
Douglas Merrill
Vasopharm Receives EUR9.7M To Advance Head Injury Product
Feb. 1, 2006
By
Douglas Merrill
Virologist: China Hiding Size Of Avian Flu Reach, Deaths
Nov. 23, 2005
By
Douglas Merrill
Virologist: China Hiding Size Of Avian Flu Reach, Deaths
Nov. 23, 2005
By
Douglas Merrill
2005's Second German IPO Prices At Low End Of Range
Nov. 2, 2005
By
Douglas Merrill
2005's Second German IPO Prices At Low End Of Range
Nov. 2, 2005
By
Douglas Merrill
Biotechnology Focal Point In Schroeder's Re-Election Bid
June 15, 2005
By
Douglas Merrill
Biotechnology Focal Point In Schroeder's Re-Election Bid
June 15, 2005
By
Douglas Merrill
View All Articles by Douglas Merrill
